Presenter's Information

Takashi Akasaka, MD

Country Japan
Specialty Interventional Cardiologist
  1. OCT Guided PCI for Calcified Lesion
  2. Physiolgy or Imaging for Identification of Vulnerable Plaque: Which One and Why?
  3. OCT Guided PCI for Calcified Lesion
  4. OCT-Guided Precise PCI for LM Bifurcation Stenting
  5. Vulnerable Plaque Identification by OCT and NIRS-IVUS
  6. Role of Imaging in Calcified Lesion Treatment
  7. Imaging-Based Treatment of Calcified Coronary Artery
  8. Optimize Your Stent: A to Z of Imaging Guidance for PCI
  9. Why Don't We Use Physiology More Often in the Cath Lab?
  10. The Clinical Value of OCT: European Consensus Document
  11. Invited Case Presentation & Focus Review: Treatment of Severe Calcified Lesion: OCT-guided Step-by Step Approach
  12. Procedural and Prognostic Impact of OCT on Coronary Intervention
  13. OCT for Guiding Complex PCI: Wisdom from Experience
  14. [Vulnerable Plaque Detection: What Is New in 2018?] OCT
  15. Bifurcation PCI with Invasive Imaging: IVUS, 3D-OCT and More
  16. Early Statin May Stabilize VP More Rapidly and Effectively: ESCORT Study Using OCT
  17. Fusion Tools for Bifurcation PCI; FFR, IVUS, or OCT - When and How?
  18. Impact of OCT- vs. IVUS-Guided PCI: OPINION and ILUMIEN
  19. Advantages/Disadvantages of FFR, iFR and Hybrid Strategy
  20. Imaging Detection of Vulnerable Plaques
  21. OCT-Guided PCI in DES Era
  22. FFR vs. iFR Usefulness & Limitation
  23. Recurrent Events After ACS: Why It Happen and How to Stop It?
  24. Detection of VP and Natural Course by OCT
  25. Native Vessel
  26. Vulnerable Plaque Detection: Between Biological and Morphological(OCT) Approaches
  27. 3D OCT: Will It Change CathLab's Landscape?
  28. OCT: Pre-intervention and Post-intervention
  29. Native Vessel
  30. OCT
  31. Vulnerable Plaque by OCT
  32. When and How to Apply? OCT-guided vs. IVUS-guided PCI
  33. IVUS and OCT in Acute Coronary Syndromes: Attenuated Plaque, TCFA, Thrombi
  34. Can We Identify Vulnerable Patients and Vulnerable Plaque? Do We Know Enough to Treat High-risk Lesions?
  35. Clinical Use Perspectives and Future Direction of OCT
  36. Procession and Regression of Atherosclerosis Assessed by OCT: Effect of Statin on TCFA
  37. DES Evaluation by OCT - Clinical-Surrogate Endpoints
  38. Pathophysiology of Acute Coronary Syndrome Assessed by OCT
  39. OCT; Comparative Imaging Results with IVUS, VH and Angioscopy
  40. Fundamentals and Pitfalls and Limitations of OCT Interpretation and Measurements
  41. What is the Futuristic Type of OCT?
  42. Invasive Imaging Is Certainly More Accurate !
  43. Evaluation of Microvascular Dysfunction
  44. Clinical Trials Update and Future Perspectives
  45. Assessment of Vulnerable Plaque by OCT: Comparison Among Intravascular Imaging Modalities
  46. Detection of Vulnerable Plaque with Optical Coherence Tomography
  47. Coronary Microvascular Resistance Estimated by A Novel Dual-Sensor (Pressure And Doppler Velocity) Guidewire Reflects Myocardial Viability After Myocardial Infarction
  48. Assessment of Plaque Morphology by OCT in Patients with Acute Coronary Syndrome
  49. Usefulness of Optical Coherence Tomography During Coronary Intervention
  50. Comparison with Histology and Possible Clinical Applications
  51. OCT and Acute Coronary Syndrome
  52. Arterial Plaque Evaluation Using OCT: A Comparison with IVUS and Histological Findings
Conference Slides
Category